<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pone.0215042.t001" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pone.0215042.t001</object-id>
 <label>Table 1</label>
 <caption>
  <title>Model parameters and their sources
   <xref ref-type="table-fn" rid="t001fn002">*</xref>.
  </title>
  <p>Annual and monthly rates in the model are recalculated to represent daily probabilities. For example, the annual rate of 0.04 will result in the daily rate of 1-(1–0.04)
   <sup>1/365</sup> = 0.00011.
  </p>
 </caption>
 <alternatives>
  <graphic id="pone.0215042.t001g" xlink:href="pone.0215042.t001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="left" rowspan="1" colspan="1">Model Parameter</th>
     <th align="center" rowspan="1" colspan="1">Value</th>
     <th align="center" rowspan="1" colspan="1">Source</th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td align="left" rowspan="1" colspan="1">Initial HIV prevalence</td>
     <td align="left" rowspan="1" colspan="1">0.05 (range 0.03–0.1)</td>
     <td align="left" rowspan="1" colspan="1">Experimental parameter</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Number of networks</td>
     <td align="left" rowspan="1" colspan="1">64 (range 1–200)</td>
     <td align="left" rowspan="1" colspan="1">Experimental parameter</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Size of network cluster</td>
     <td align="left" rowspan="1" colspan="1">average 8 (range: 2–17)</td>
     <td align="left" rowspan="1" colspan="1">Bobashev and Zule, (2010) [
      <xref rid="pone.0215042.ref023" ref-type="bibr">23</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Proportion of people in the cluster participating in sharing</td>
     <td align="left" rowspan="1" colspan="1">0.5 (range 0.3–0.8)</td>
     <td align="left" rowspan="1" colspan="1">Experimental parameter</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Number of times sharing with buddies</td>
     <td align="left" rowspan="1" colspan="1">High risk: 30 per month (range 20–30) Low risk: 5 per month (range 1–5)</td>
     <td align="left" rowspan="1" colspan="1">Zule et al. (2002, 2009) [
      <xref rid="pone.0215042.ref028" ref-type="bibr">28</xref>, 
      <xref rid="pone.0215042.ref033" ref-type="bibr">33</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Number of times injecting with a stranger</td>
     <td align="left" rowspan="1" colspan="1">High risk: 10 times per year (range 8–20) Low risk: 1 time per year (range 0–2)</td>
     <td align="left" rowspan="1" colspan="1">Experimental parameter</td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Removal rate (includes PWID HIV+ all-cause mortality and PWID leaving the population [i.e., stop injecting]).</td>
     <td align="left" rowspan="1" colspan="1">0.04 per year (range 0.02–0.06)</td>
     <td align="left" rowspan="1" colspan="1">Bailey et al. (2007) [
      <xref rid="pone.0215042.ref038" ref-type="bibr">38</xref>], De et al. (2007) [
      <xref rid="pone.0215042.ref039" ref-type="bibr">39</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Risk of HIV transmission assuming HDS and PH</td>
     <td align="left" rowspan="1" colspan="1">0.008 per act (range 0.005–0.01)</td>
     <td align="left" rowspan="1" colspan="1">Hudgens et al. (2001, 2002) [
      <xref rid="pone.0215042.ref024" ref-type="bibr">24</xref>, 
      <xref rid="pone.0215042.ref025" ref-type="bibr">25</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Risk multiplier for an acute stage of HIV infection</td>
     <td align="left" rowspan="1" colspan="1">10 (range 5–30)</td>
     <td align="left" rowspan="1" colspan="1">Jacquez et al.(1994) [
      <xref rid="pone.0215042.ref036" ref-type="bibr">36</xref>], Fiebig et al. (2003) [
      <xref rid="pone.0215042.ref037" ref-type="bibr">37</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Risk multiplier for muscle injection</td>
     <td align="left" rowspan="1" colspan="1">0.29 (range 0.02–0.06)</td>
     <td align="left" rowspan="1" colspan="1">Baggaley et al. (2006) [
      <xref rid="pone.0215042.ref030" ref-type="bibr">30</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Risk multiplier for heating</td>
     <td align="left" rowspan="1" colspan="1">0.1 (range 0.05–0.15)</td>
     <td align="left" rowspan="1" colspan="1">Clatts et al. (1999) [
      <xref rid="pone.0215042.ref012" ref-type="bibr">12</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Risk multiplier for an extra rinse of an HDS syringe</td>
     <td align="left" rowspan="1" colspan="1">0.17 (range 0.1–0.2)</td>
     <td align="left" rowspan="1" colspan="1">Zule et al. (1997, 2018) [
      <xref rid="pone.0215042.ref021" ref-type="bibr">21</xref>, 
      <xref rid="pone.0215042.ref022" ref-type="bibr">22</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Risk multiplier for an extra rinse of an LDS syringe</td>
     <td align="left" rowspan="1" colspan="1">0.004 (range 0.002–0.008)</td>
     <td align="left" rowspan="1" colspan="1">Zule et al. (1997, 2018) [
      <xref rid="pone.0215042.ref021" ref-type="bibr">21</xref>, 
      <xref rid="pone.0215042.ref022" ref-type="bibr">22</xref>]
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Rate of sexual HIV</td>
     <td align="left" rowspan="1" colspan="1">10
      <sup>−4</sup> per year (range 0.5
      <xref ref-type="table-fn" rid="t001fn002">*</xref>10
      <sup>−4</sup>–2 
      <xref ref-type="table-fn" rid="t001fn002">*</xref>10
      <sup>−4</sup>)
     </td>
     <td align="left" rowspan="1" colspan="1">CDC (2017) [
      <xref rid="pone.0215042.ref040" ref-type="bibr">40</xref>] incidence rates through sexual contacts
     </td>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="t001fn001">
   <p>Note. SATH-CAP = Sexual Acquisition and Transmission of HIV Cooperative Agreement Program; PWID = injecting drug user; BTH = black tar heroin, PH = powder heroin, HDS = high dead-space syringe; LDS = low-dead-space syringe.</p>
  </fn>
  <fn id="t001fn002">
   <p>*“Experimental” parameter means that the value of the parameter varies between different geographic areas, cultures, etc. For illustration purposes, we use a value that is considered reasonable. We use experimental parameters to design “what if experiments” aimed at evaluating intervention strategies and conducting sensitivity analysis.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
